These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9140672)

  • 21. [Effects of m-nisoldipine on ischemic arrhythmia in conscious rats].
    An RH; Fu SX; Li YS
    Zhongguo Yao Li Xue Bao; 1989 Mar; 10(2):151-6. PubMed ID: 2816416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Protection of ischemic myocardium].
    Kobyashi A
    Kokyu To Junkan; 1989 Apr; 37(4):395-403. PubMed ID: 2568011
    [No Abstract]   [Full Text] [Related]  

  • 23. Long term effects of nisoldipine on the progression of coronary atherosclerosis and the occurrence of clinical events: the NICOLE study.
    Dens JA; Desmet WJ; Coussement P; De Scheerder IK; Kostopoulos K; Kerdsinchai P; Supanantaroek C; Piessens JH
    Heart; 2003 Aug; 89(8):887-92. PubMed ID: 12860866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An updated meta-analysis of calcium-channel blockers in the prevention of restenosis after coronary angioplasty.
    Dens J; Desmet W; Piessens J
    Am Heart J; 2003 Mar; 145(3):404-8. PubMed ID: 12660661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium-channel blockers for hypertension--uncertainty continues.
    Cutler JA
    N Engl J Med; 1998 Mar; 338(10):679-81. PubMed ID: 9486999
    [No Abstract]   [Full Text] [Related]  

  • 26. Utility of levosimendan, a new calcium sensitizing agent, in the treatment of cardiogenic shock due to myocardial stunning in patients with ST-elevation myocardial infarction: a series of cases.
    García-González MJ; Domínguez-Rodríguez A; Ferrer-Hita JJ
    J Clin Pharmacol; 2005 Jun; 45(6):704-8. PubMed ID: 15901754
    [No Abstract]   [Full Text] [Related]  

  • 27. The calcium antagonist nisoldipine improves the functional recovery of reperfused myocardium only when given before ischemia.
    Ehring T; Böhm M; Heusch G
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):63-74. PubMed ID: 1383632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion.
    du Toit EF; Opie LH
    Circ Res; 1992 May; 70(5):960-7. PubMed ID: 1568304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of percutaneous transluminal coronary angioplasty in treating acute myocardial infarct patients].
    Ekha IaE; Serka TT; Rebane TKh; Lukha OA
    Kardiologiia; 1984 Sep; 24(9):44-7. PubMed ID: 6240563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Termination of reperfusion arrhythmia by coronary artery occlusion.
    Grech ED; Ramsdale DR
    Br Heart J; 1994 Jul; 72(1):94-5. PubMed ID: 8068480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance.
    Francone M; Bucciarelli-Ducci C; Carbone I; Canali E; Scardala R; Calabrese FA; Sardella G; Mancone M; Catalano C; Fedele F; Passariello R; Bogaert J; Agati L
    J Am Coll Cardiol; 2009 Dec; 54(23):2145-53. PubMed ID: 19942086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial protection with calcium-channel blockers during ischaemia and reperfusion by PTCA.
    Chouairi S; Carrie D; Puel J
    Eur Heart J; 1995 Aug; 16 Suppl H():3-8. PubMed ID: 8846802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Protective effects of m-nisoldipine and nisoldipine on myocardial damage in working rabbit hearts after ischemia-reperfusion].
    Zhang HL; Fu SX; Li YS
    Zhongguo Yao Li Xue Bao; 1989 Jan; 10(1):49-53. PubMed ID: 2554666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.
    Estacio RO; Jeffers BW; Hiatt WR; Biggerstaff SL; Gifford N; Schrier RW
    N Engl J Med; 1998 Mar; 338(10):645-52. PubMed ID: 9486993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microvascular obstruction after reperfusion therapy for acute myocardial infarctions, an "open and shut case".
    Bailey SR
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1008-9. PubMed ID: 19953517
    [No Abstract]   [Full Text] [Related]  

  • 36. Possible survival benefit from concomitant beta-but not calcium-antagonist therapy during reperfusion for acute myocardial infarction.
    Ellis SG; Muller DW; Topol EJ
    Am J Cardiol; 1990 Jul; 66(2):125-8. PubMed ID: 1973588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of magnesium sulfate pretreatment and significance of matrix metalloproteinase-1 and interleukin-6 levels in coronary reperfusion therapy for patients with acute myocardial infarction.
    Shibata M; Ueshima K; Harada M; Nakamura M; Hiramori K; Endo S; Sato N; Mukaida H; Suzuki T; Suzuki T; Inada K
    Angiology; 1999 Jul; 50(7):573-82. PubMed ID: 10431997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxygen radicals and calcium ion flux: role in reperfusion injury following AMI.
    Sharber J
    Dimens Crit Care Nurs; 1994; 13(5):256-62. PubMed ID: 7988339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reperfusion injury, microvascular dysfunction, and cardioprotection: the "dark side" of reperfusion.
    Prasad A; Stone GW; Holmes DR; Gersh B
    Circulation; 2009 Nov; 120(21):2105-12. PubMed ID: 19933949
    [No Abstract]   [Full Text] [Related]  

  • 40. ["No reflow" phenomenon after reperfusion].
    Ito H
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):182-8. PubMed ID: 12436525
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.